Elmwood Wealth Management, Inc. Red Hill Biopharma Ltd. Transaction History

Elmwood Wealth Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.65 - $3.12 $2,145 - $4,056	-1,300 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$2.31 - $5.85 $693 - $1,755	300 Added 30.0%	1,300 $3,000
Q1 2021 May 13, 2021	BUY	$6.98 - $11.29 $6,980 - $11,290	1,000 New	1,000 $7,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.